First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
-
-
Incyte to Acquire Vega Therapeutics, Subsidiary of Star Therapeutics, for $1.25 billion, Expanding its Hematology Portfolio into Bleeding Disorders
On Jun. 8, 2026, Incyte announced it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned…
-
Johnson & Johnson to Acquire Firefly Bio for $1 Billion in Cash to Expand Oncology Pipeline
On Jun. 8, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Firefly…
-
Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billion
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
-
study finds Indoor air contains greater diversity of airborne fungi than previously thought
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
-
Debugging California: Fighting mosquitoes with mosquitoes
On Jun. 4, 2026, a program called Debug—run by Google’s health research arm—has applied to the EPA to…
-
Bioprinting Cartilage, Producing Stem Cells Fill ISS Research Schedule
On Jun. 4, 2026, 3D bioprinting and stem cell research were the main research topics aboard the International…
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
-
Flesh-eating screwworm may have been detected in South Texas, USDA says
On Jun. 3, 2026, an infestation of the flesh-eating screwworm parasite may have been detected in South Texas,…
-
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics Worth Up to $2 Billion
On Jun. 3, 2026, Alnylam Pharmaceuticals, the leading RNAi therapeutics company, and Inceptive Nucleics, which builds foundation models…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Measles | NIH | Vaccine
Measles cases mount in Florida, highest number reported in 25 years
On Jun. 2, 2026, The Florida Department of Health said there have been 154 measles cases in the…
-
Microrobots repair spinal cord
On Jun. 2, 2026, a research team from ETH Zurich and the University of Zurich (UZH) announced it…
-
CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak response
On Jun. 2, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced New funding will support the continued…
-
CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates
On May 31, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced it will urgently accelerate development of…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Measles | NIH | Vaccine
U.S. nears 2,000 measles cases as scientists note brain inflammation, pneumonia in hospital cases
On May 29, 2026, the U.S. Centers for Disease Control and Prevention (CDC) confirmed 31 new measles cases…
-
Pfizer and China’s Innovent Biologics Enter Global Strategic Collaboration worth $9.85 billion to Accelerate Development of Oncology Medicines
On May 28, 2026, Pfizer and Innovent Biologics announced the companies have entered into a strategic global licensing…
-
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
On May 28, 2026, the University of California, San Francisco (UCSF) announced that for the first time, researchers…
-
Abbott secures CE Mark for world’s first dual glucose-ketone sensing technology for people with diabetes
On May 27, 2026, Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing…
-
New MRI sensors developed at MIT sensitively detect target molecules in the brain and body.
On May 27, 2026, researchers at Massachusetts Institute of Technology announced that MRI can noninvasively capture detailed images…
-
Lilly announces three acquisitions to build infectious disease portfolio for $3.8 Billion in Cash
On May 26, 2026, Eli Lilly announced agreements to acquire three companies, Curevo, LimmaTech Biologics, and Vaccine Company,…
-
New kidney stone treatment powered by biomedical engineering research receives FDA approval
On May 25, 2026, Virginia Tech researchers announced they have received Food and Drug Administration (FDA) approval for…
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus
On May 22, 2026, Gilead Sciences announced announced that the U.S. Food and Drug Administration (FDA) has granted…
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
-
Engage Bio Acquired by Lilly for $202 million in cash to Accelerate Development of Non-Viral Genetic Medicines
On May 20, 2026, Engage Biologics, a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it…
-
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Artificial Womb Construction Nearing Completion
On May 19, 2026, Colossal Biosciences announced it is developing a functional artificial womb capable of growing a…
-
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Colossal Biosciences Artificial Egg Hatches 26 Chickens in Breakthrough Step Toward Dodo and Moa De-Extinction
On May 19, 2026, Colossal Biosciences announced their artificial egg — a silicone-membrane synthetic shell system — successfully…
-
Scientists solve 200-year-old puzzle of how tobacco plants make nicotine
On May 18, 2026, scientists from the University of York and University of Copenhagen announced they have uncovered…
-
European Union and Singapore Back CEPI’s Plan to Boost Global Defences Against Epidemic and Pandemic Threats
On May 18, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) welcomed landmark financial commitments from two of…
-
Ebola Epidemic caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern
On May 17, 2026, the Director-General of the World Health Organization (WHO) announced that the Ebola disease caused…
-
Stretchy implants could stick to arteries to treat high blood pressure
On May 15, 2026, researchers at Penn State have developed tiny devices that gently shock one of the…
